메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The correlation between serum anti-tuberculosis (TB) drug levels and the drug-inducedhepatotoxicity (DIH) remains unclear. The purpose of this study was to investigate whetheranti-TB DIH is associated with basal serum drug levels. Serum peak levels of isoniazid (INH),rifampicin (RMP), pyrazinamide (PZA), and ethambutol (EMB) were analyzed in bloodsamples 2 hr after the administration of anti-TB medication. Anti-TB DIH and mild liverfunction test abnormality were diagnosed on the basis of laboratory and clinical criteria. Serum anti-TB drug levels and other clinical factors were compared between thehepatotoxicity and non-hepatotoxicity groups. A total of 195 TB patients were included inthe study, and the data were analyzed retrospectively. Seventeen (8.7%) of the 195patients showed hepatotoxicity, and the mean aspartate aminotransferase/alanineaminotransferase levels in the hepatotoxicity group were 249/249 IU/L, respectively. Among the 17 patients with hepatotoxicity, 12 showed anti-TB DIH. Ten patients showedPZA-related hepatotoxicity and 2 showed INH- or RMP-related hepatotoxicity. However,intergroup differences in the serum levels of the 4 anti-TB drugs were not statisticallysignificant. Basal serum drug concentration was not associated with the risk anti-TB DIH inpatients being treated with the currently recommended doses of first-line anti-TBtreatment drugs.

목차

등록된 정보가 없습니다.

참고문헌 (32)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0